Germany’s Scaleup Gap: Why 92% of Exits Are Trade Sales

Germany has solved startup creation and not startup scaling, and the 2026 government strategy is an explicit admission of exactly that. Understanding where the capital stops explains why successful German companies end up foreign-owned. This case study opens the startup pillar of the Germany Company Stories hub.

Where exactly does the capital stop?

At roughly the Series B to C boundary, where round sizes move from tens of millions into hundreds of millions. Seed and early venture funding in Germany is now reasonably deep, supported by domestic funds, public co-investment vehicles and business angels.

Above that threshold the domestic investor base thins dramatically. Very few German funds can write a fifty or hundred million euro cheque, and fewer still can follow their position across several subsequent rounds, which is what a company scaling toward a billion-euro valuation requires.

The consequence is not that companies fail to raise. They raise successfully from American, British and increasingly Gulf and Asian investors, who take the position that domestic capital declined.

Ownership then follows control. An investor base concentrated abroad shapes governance, listing venue preference and eventual exit route, which is why so many German scaleups end up sold to foreign strategic buyers or listed on foreign exchanges.

Why do German institutions not invest in venture?

Regulation, mandate and culture, in that order of importance. Insurance companies and pension vehicles operate under solvency and prudential rules that penalise illiquid, volatile assets with capital charges, making venture allocations expensive relative to bonds.

Mandate is the second constraint. Many German institutional investors have liability profiles requiring predictable returns, and venture capital's return distribution, where most funds underperform and a few produce outsized results, is difficult to justify to trustees.

Culture is the third. The German savings tradition is concentrated in bank deposits, life insurance and real estate, so the household capital that in other markets flows to equities through pension funds is instead intermediated through institutions with conservative mandates.

The cumulative effect is stark: capital pools of roughly two point eight trillion euros and private wealth around ten trillion coexist with a domestic venture industry a fraction of the size the economy would support. The constraint is allocation policy rather than the existence of money, which is why the BioNTech case recurs across sectors.

Why does the exit route matter so much?

Because a trade sale ends the company as an independent entity while a listing creates one. When ninety-two per cent of exits are sales, the ecosystem produces valuable assets for other people's corporate portfolios rather than a cohort of independent public companies.

The secondary effects compound. A listed company keeps its headquarters, its senior team and its acquisition capability in the country, and it becomes an acquirer of the next generation of startups. A company sold to a foreign buyer typically loses all three within a few years.

The talent effect is equally significant. Ecosystems need people who have built and run companies at scale, and those people are created by companies that reach scale independently rather than by integration teams at foreign acquirers.

The reasons listings are rare include a thin domestic base of specialist investors and analysts, listing costs and disclosure burdens that fall heavily on mid-sized companies, and the simple fact that a trade sale offers certainty while a listing offers a process with an uncertain outcome.

What does the 2026 strategy actually propose?

A hundred and fifty-two measures across financing, research transfer, defence and security technology, bureaucracy reduction, public procurement, talent and internationalisation. The volume is less significant than the reframing.

The shift is from startup promotion to scaleup capacity, with selected companies treated as strategic infrastructure rather than as generic economic activity. That language matters because it implies procurement preference and state co-investment in specific sectors rather than neutral support.

The financing measures target the institutional allocation problem directly, seeking to mobilise domestic capital pools into venture and growth funds, alongside continued expansion of public fund-of-funds vehicles.

Public procurement is the underappreciated element. A government that buys from domestic scaleups provides revenue rather than subsidy, which is a more durable form of support and one that European states have historically used far less effectively than the United States has.

Is defence and dual-use technology changing the picture?

Substantially, and faster than any policy measure. European defence spending increases have created a market with government as the customer, which resolves the demand-side uncertainty that deep technology startups usually face.

That also changes the investor calculus. A company with government contracts has visible revenue and a strategic rationale that attracts both venture and sovereign capital, and it is politically difficult to sell to a foreign acquirer, which pushes toward domestic ownership or listing.

The strategy explicitly identifies defence and security technology as a priority, which is a significant departure for a country where many funds previously had exclusions preventing such investment.

The risk is the usual one with procurement-driven markets: companies optimised for a government customer frequently cannot compete commercially, and a sector built on defence budgets is exposed to the political cycle that funds it.

What should a founder actually do about this?

Plan the capital structure for the whole journey rather than for the next round. Decisions made at seed stage about jurisdiction, share classes, option pools and investor rights determine what is possible at Series C.

The practical specifics matter. A structure that a foreign growth investor finds unfamiliar adds friction and cost at exactly the stage where speed matters most, and converting later is expensive and occasionally impossible without triggering tax events.

The second point is to build the investor relationship two rounds ahead. Growth funds invest in companies they have tracked for eighteen months, so the correct time to meet a Series C investor is during the Series A.

The third is to consider public co-investment seriously rather than dismissively. Public vehicles investing alongside private leads have become a meaningful part of the German capital stack, and the terms are generally market-standard, as the public venture capital analysis describes.

How do secondaries change the picture?

They relieve the pressure that would otherwise force early exits. A secondary transaction lets founders, employees and early investors realise part of their holdings without the company being sold or listed, which removes the liquidity motive from the exit decision.

European secondary activity has grown substantially, and large transactions at multi-billion valuations now provide the liquidity event that a listing would have supplied a decade ago.

The consequence is companies staying private longer, which is good for the company and reduces the supply of public technology companies further. The value creation between a five billion and a twenty billion valuation now accrues to private investors rather than to public markets.

For employees this matters directly. Options that cannot be exercised or sold have limited motivational value, and companies that arrange periodic employee liquidity retain people far better than those that ask them to wait indefinitely.

What is the option taxation issue?

Historically the largest structural disadvantage German startups faced in competing for talent, and now partially addressed. The core problem was taxation at the point of exercise or grant rather than at sale, meaning an employee could owe tax on shares they could not sell.

Reforms have deferred taxation in defined circumstances and raised the thresholds for qualifying companies, which improves the position considerably without matching the treatment available in some competing markets.

The practical implication for founders is to model the employee's after-tax outcome rather than the headline option value. A package that appears competitive on paper and produces a tax liability before any liquidity is not competitive in practice, and candidates who have experienced it once will recognise the structure immediately.

What does public procurement actually change?

It supplies revenue rather than capital, which is the more valuable input. A startup with a government contract has proof of demand, reference credibility and cash flow, all of which reduce the amount of equity it needs to raise.

The obstacle in Germany and across Europe has been procurement processes designed to minimise risk, which favour large established vendors with long track records and effectively exclude young companies.

The measures that work are simple and administrative: raising thresholds for simplified procedures, allowing innovation partnerships, accepting references from other public buyers, and shortening payment terms so that a small company can survive the contract.

Taken together, the German position is a strong front end attached to a weak back end. Formation, talent and early capital are competitive; growth capital, listing depth and institutional allocation are not, and the 2026 strategy is the first policy document to state that division explicitly rather than treating startup activity as a single undifferentiated objective.

For an operator or investor assessing German opportunities, the practical read is that assets are frequently available at more reasonable valuations than in deeper capital markets, precisely because the domestic competition for growth positions is thinner. That is the mirror image of the founder's problem.

Frequently Asked Questions